Quick Look Market Closing Price:
At the close: Dow +1.06% to 12587. S&P +1.2% to 1334. Nasdaq +1.18% to 2871.
Treasurys: 30-year +0.01%. 10-yr -0.05%. 5-yr -0.03%.
Commodities: Crude -0.05% to $90.81. Gold -0.88% to $1557.45.
Currencies: Euro -0.34% vs. dollar. Yen +0.07%. Pound +0.29%.
After Hours News:
Repros Therapeutics (RPRX) says the FDA has advised the company it must complete an integrated safety analysis of completed studies of oral Proellex. Once completed, the report must be submitted to the FDA for review prior to any additional oral trials. Shares -5.6% AH
Perfect World (PWRD): Q1 EPS of $0.72 misses by $0.01. Revenue of $114.1M (+3% Y/Y) misses by $2.8M. Shares -14.8% AH.
DryShips (DRYS): Q1 EPS of -$0.11 misses by $0.06. Revenue of $247.5M (+19% Y/Y) misses by $20M. Shares -3.1% AH.
Synergetics (SURG) -8.8% AH after issuing downside FQ3 guidance, seeing EPS of $0.04-$0.06 vs. $0.08 consensus and revenues of $14.4M-$14.7M vs. $16.25M consensus; ophthalmic sales are expected to drop ~9% Y/Y. SURG cites difficulties in Europe, which is depressing demand for ophthalmic disposables and exerting an unfavorable foreign currency impact .
Research In Motion (RIMM) has resumed trading, and is now down 11.2% AH, making new multi-year lows in the process. With rumors already in place about the hiring of strategic advisers, and a sale not mentioned among the options RIM claims JPMorgan and RBC will advise on, investors are focusing on RIM's guidance for an FQ1 loss.
For the latest updates on the stock market, visit,